|
業務類別
|
Biotechnology |
|
業務概覽
|
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy. |
| 公司地址
| Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7 |
| 電話號碼
| +353 16347800 |
| 傳真號碼
| +353 16347850 |
| 公司網頁
| https://www.jazzpharmaceuticals.com |
| 員工數量
| 2890 |
| Ms. Renee D. Gala |
President, Chief Executive Officer and Director |
美元 1.00M |
08/06/2026 |
| Dr. Robert Iannone, M.D. |
Executive Vice President, Global Head of Research and Development and Chief Medical Officer |
美元 793.08K |
08/06/2026 |
| Mr. Philip L. Johnson |
Executive Vice President and Chief Financial Officer |
美元 741.35K |
08/06/2026 |
| Ms. Neena M. Patil |
Executive Vice President and Chief Legal Officer |
美元 715.48K |
08/06/2026 |
| Ms. Patricia Carr |
Senior Vice President and Chief Accounting Officer |
-- |
08/06/2026 |
| Ms. Samantha Pearce |
Executive Vice President and Chief Commercial Officer |
美元 695.67K |
08/06/2026 |
| Ms. Mary Elizabeth Henderson |
Senior Vice President, Technical Operations |
-- |
08/06/2026 |
|
|
| Mr. Bruce C. Cozadd |
Chairperson of the Board |
08/06/2026 |
| Mr. Patrick G. Enright, M.B.A. |
Independent Director |
08/06/2026 |
| Dr. Norbert G. Riedel,PhD |
Independent Director |
08/06/2026 |
| Dr. Ted W. Love, M.D. |
Independent Director |
08/06/2026 |
| Mr. Rick E. Winningham |
Lead Independent Director |
08/06/2026 |
| Ms. Heather Ann McSharry |
Independent Director |
08/06/2026 |
| Mr. Patrick Thomas Kennedy |
Independent Director |
08/06/2026 |
| Mr. Seamus C. Mulligan |
Independent Director |
08/06/2026 |
| Ms. Renee D. Gala |
President, Chief Executive Officer and Director |
08/06/2026 |
| Ms. Laura J. Hamill |
Independent Director |
08/06/2026 |
| Ms. Jennifer E. Cook |
Independent Director |
08/06/2026 |
| Dr. Mark D. Smith, M.D. |
Independent Director |
08/06/2026 |
|
|
|
|
